Stockreport

Taysha draws bullish view at Piper Sandler on lead asset [Seeking Alpha]

ACADIA Pharmaceuticals Inc.  (ACAD) 
Last acadia pharmaceuticals inc. earnings: 2/26 04:05 pm Check Earnings Report
PDF the potential of biotech's lead asset, TSHA-102, targeted at the rare neurodevelopmental disorder Rett syndrome. Issuing a $9 price target on the stock, Piper argued t [Read more]